Table 7.

Predictors of treatment by 12 months of eligibility in patients who were treatment-eligible

	Unadjusted HR (95% CI)	p Value	Adjusted HR (95% CI)	p Value
Age	1.01 (1.00 to 1.02)	0.003	1.02 (1.01 to 1.03)	0.003
Male	1.31 (1.04 to 1.66)	0.02	1.42 (1.06 to 1.90)	0.02
Non-Asian	0.88 (0.47 to 1.66)	0.70	0.54 (0.23 to 1.29)	0.17
Community Site	0.77 (0.61 to 0.98)	0.04	0.76 (0.55 to 1.03)	0.08
HBeAg-Positive	1.36 (1.06 to 1.76)	0.02	1.28 (0.86 to 1.91)	0.23
Baseline ALT	2.51 (1.89 to 3.33)	<0.0001	2.77 (1.93 to 3.99)	<0.0001
Baseline HBV DNA	1.13 (1.05 to 1.21)	0.001	1.09 (0.97 to 1.22)	0.15
Cirrhosis	1.83 (1.26 to 2.68)	0.002	1.45 (0.89 to 2.38)	0.14

Values are presented as median (range).

ALT, alanine aminotransferase; HBeAg, hepatitis B e antigen; HBV DNA, hepatitis B virus DNA.